{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T09:28:35Z","timestamp":1745832515769},"reference-count":10,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","jdsjournal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Dermatological Science"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.jdermsci.2016.06.009","type":"journal-article","created":{"date-parts":[[2016,6,24]],"date-time":"2016-06-24T05:15:38Z","timestamp":1466745338000},"page":"101-104","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["MAGEA3 methylation status is associated with prognosis of malignant peripheral nerve sheath tumor and with neurofibroma type in neurofibromatosis type 1"],"prefix":"10.1016","volume":"84","author":[{"given":"Yoshimasa","family":"Nobeyama","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidemi","family":"Nakagawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jdermsci.2016.06.009_bib0005","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1016\/j.ajpath.2010.12.056","article-title":"The pathoetiology of neurofibromatosis 1","volume":"178","author":"Jouhilahti","year":"2011","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.jdermsci.2016.06.009_bib0010","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1111\/j.1349-7006.2009.01303.x","article-title":"Cancer\/testis (CT) antigens: potential targets for immunotherapy","volume":"100","author":"Caballero","year":"2009","journal-title":"Cancer Sci."},{"key":"10.1016\/j.jdermsci.2016.06.009_bib0015","doi-asserted-by":"crossref","first-page":"3289","DOI":"10.4049\/jimmunol.172.5.3289","article-title":"Vaccine-induced CD4+ T cell responses to MAGE-3 protein in lung cancer patients","volume":"172","author":"Atanackovic","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.jdermsci.2016.06.009_bib0020","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1073\/pnas.0707140104","article-title":"Booster vaccination of cancer patients with MAGE-A3 protein reveals long-term immunological memory or tolerance depending on priming","volume":"105","author":"Atanackovic","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jdermsci.2016.06.009_bib0025","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1182\/blood-2008-07-168666","article-title":"Peripheral blood lymphocytes genetically modified to express the self\/tumor antigen MAGE-A3 induce antitumor immune responses in cancer patients","volume":"113","author":"Fontana","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.jdermsci.2016.06.009_bib0030","doi-asserted-by":"crossref","first-page":"3719","DOI":"10.4049\/jimmunol.180.6.3719","article-title":"The use of filamentous bacteriophage fd to deliver MAGE-A10 or MAGE-A3 HLA-A2-restricted peptides and to induce strong antitumor CTL responses","volume":"180","author":"Sartorius","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.jdermsci.2016.06.009_bib0035","first-page":"1111","article-title":"Potential role of dendritic cell vaccination with MAGE peptides in gastrointestinal carcinomas","volume":"20","author":"Tanaka","year":"2008","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.jdermsci.2016.06.009_bib0040","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.cell.2007.02.006","article-title":"Epigenetics: a landscape takes shape","volume":"128","author":"Goldberg","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.jdermsci.2016.06.009_bib0045","first-page":"575","article-title":"Neurofibromatosis. Conference statement. National Institutes of Health Consensus Development Conference","volume":"45","author":"Anon","year":"1988","journal-title":"Arch Neurol"},{"key":"10.1016\/j.jdermsci.2016.06.009_bib0050","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1002\/biot.200800160","article-title":"Melanoma vaccine candidates from chimeric hepatitis B core virus-like particles carrying a tumor-associated MAGE-3 epitope","volume":"3","author":"Kazaks","year":"2008","journal-title":"Biotechnol. J."}],"container-title":["Journal of Dermatological Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923181116301268?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923181116301268?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,11]],"date-time":"2018-09-11T01:54:49Z","timestamp":1536630889000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923181116301268"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":10,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["S0923181116301268"],"URL":"https:\/\/doi.org\/10.1016\/j.jdermsci.2016.06.009","relation":{},"ISSN":["0923-1811"],"issn-type":[{"value":"0923-1811","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MAGEA3 methylation status is associated with prognosis of malignant peripheral nerve sheath tumor and with neurofibroma type in neurofibromatosis type 1","name":"articletitle","label":"Article Title"},{"value":"Journal of Dermatological Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdermsci.2016.06.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Japanese Society for Investigative Dermatology. Published by Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}